Menu

Incomplete Immunity

By combining experimental data with computer models, researchers were able to predict a pathogen’s evolution toward more virulence.

Jun 1, 2018
Jim Daley

BYE BYE BIRDIE: A study suggests a weak immune response could drive pathogens toward greater virulence. MARIE READ

EDITOR’S CHOICE IN EVOLUTION

The paper
A.E. Fleming-Davies et al., “Incomplete host immunity favors the evolution of virulence in an emergent pathogen,” Science, 359:1030-33, 2018.

FINCH KILLER
Since 1994, an epidemic of conjunctivitis caused by the bacterium Mycoplasma gallisepticum has ravaged house finch (Haemorhous mexicanus) populations across North America. Arietta Fleming-Davies and Dana Hawley, disease ecologists at the University of San Diego and Virginia Tech, respectively, noted that many birds that had been infected remained susceptible to later infection. The phenomenon reminded Fleming-Davies of findings by other researchers that when a vaccine partially protects a host, it can drive a pathogen to evolve more virulence. (See “Do Pathogens Gain Virulence as Hosts Become More Resistant?The Scientist, October 2017.)

BIRD IN A CAGE
To find out whether something similar was happening in finches, the duo and their colleagues simulated the natural epidemic in the lab, infecting captive birds with increasingly virulent strains of M. gallisepticum and observing the severity of their symptoms. Fleming-Davis then used the data to model infection and the evolution of pathogen virulence in the wild.

CHINKS IN THE ARMOR
The model predicted almost twice as much virulence when bacterial attackers were confronted with incomplete immunity compared to zero immunity, Fleming-Davis tells The Scientist. This suggests, the authors write, that a weak immune response favors nastier pathogens that can overcome defenses.

NOT THE WHOLE STORY
That idea is “an interesting concept, especially as it relates to vaccine research,” says Molly Staley, an evolutionary biologist at the Brookfield Zoo, “but it doesn’t quite fit with what we know” about M. gallisepticum. The birds’ ability to resist manipulation of their immune systems by the bacteria is the primary driver of the pathogen’s increased virulence in the wild, Staley explains, adding that most of the birds infected in the wild are immunologically naïve juveniles, so the responses of previously infected birds likely have only a small effect on virulence evolution.

Correction (June 21): The photo credit on the image that accompanies this article originally referred to the wrong photographer and has been corrected. The Scientist regrets the error.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.
Corning Introduces New 1536-well Spheroid Microplate
Corning Introduces New 1536-well Spheroid Microplate
High-throughput spheroid microplate benefits cancer research, drug screening